Evidence map›Paper›PMID 41103502›Full record

ReviewEXCLI journal2025

Advancing cancer research through 3D cell culture models.

Isidora Panez-Toro, Joshua Mountford, Javier Muñoz-Garcia, Dominique Heymann

Abstract readReview
In one paragraph

Review in EXCLI journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Isidora Panez-ToroNantes Université, CNRS, UMR6286, US2B, Biological Sciences and Biotechnologies unit, Nantes 44322, France.
Joshua MountfordNantes Université, CNRS, UMR6286, US2B, Biological Sciences and Biotechnologies unit, Nantes 44322, France.
Javier Muñoz-GarciaNantes Université, CNRS, UMR6286, US2B, Biological Sciences and Biotechnologies unit, Nantes 44322, France.
Dominique HeymannNantes Université, CNRS, UMR6286, US2B, Biological Sciences and Biotechnologies unit, Nantes 44322, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a multifactorial disease with cellular proliferative molecular networks and immune evasion properties. The well-known cancer intra- and inter-tumoral heterogeneity presents a notable limitation of the current histological and diagnostic techniques. Thus, biasing the risk of invasiveness and restricting its broader application in oncology in prognostic, survival, and treatment response differences between patients. Monolayer cell cultures have been a consistent

Indexed as

3D cell culturedroplet-based 3D cultureliquid-based 3D culturemicrofluidicsorgan-on-a-chipscaffold-based 3D culture

Identifiers

PMID41103502
PMCPMC12521747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.